ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.2522
Delayed Data
As of May 25
 -0.0018 / -0.71%
Today’s Change
0.21
Today|||52-Week Range
0.83
-29.94%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +1,287.79% increase from the last price of 0.25.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$0.00
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.25%
 
 
 
 
 
 
Growthannually 11.43%
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
Key to the earnings and sales forecast charts.